Abstract
Oral anticoagulant (OAC) therapy is usually monitored by noting changes in a tissue factor-induced coagulation time (“prothrombin time”) test on whole blood or plasma and expressed as an International Normalized Ratio (INR). Current point-of-care (POC) instruments for monitoring OAC therapy display both the calculated prothrombin time (PT) and the INR. Although many attempts have been made to improve the accuracy and precision of INR determinations in daily practice, it is impossible to eliminate all uncertainty because the PT test is sensitive to multiple factors in the patient's blood specimen. The accuracy of the average INR determined with a POC instrument depends on its calibration against reference methods. Quality control (QC) materials for POC devices are different from patients' samples and may not exactly reflect the real clinical situation. Nevertheless, internal and external QC schemes for POC devices are valuable to investigate their performance in daily practice. Calibration can be improved by direct comparison of a POC system against an established international reference preparation method. In general, the precision of the INR measured with a POC device is slightly lower than the precision achieved with available automated laboratory instruments. The greater imprecision should be weighed against the clinical advantages of a POC testing device.
Similar content being viewed by others
References
WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Technical Report Series. Forty–eighth Report. WHO, Geneva, 1999.
Van den Besselaar AMHP. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 1996;26(Suppl 4):248–265.
Van den Besselaar AMHP, Houbouyan LL, Aillaud MF, et al. Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human, and recombinant human tissue factor preparations. Thromb Haemost 1999;81:66–70.
Van den Besselaar AMHP, Meeuwisse–Braun J, Witteveen E, Van Meegen E. Effect of evacuated blood collection tubes on thromboplastin calibration. Thromb Haemost 1998;79:1062–1063.
Loeliger EA, Van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 1985;53:148–154.
Attermann J. Monitoring oral anticoagulant therapy: measuring coagulant activity. Ph.D. thesis. Faculty of Health Sciences, University of Aarhus, 2000.
Taberner DA, Poller L, Thomson JM, Darby KV. Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR). J Clin Pathol 1989;42:92–96.
Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993;70:921–924.
Van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995;6:726–732.
Van den Besselaar AMHP, Meeuwisse–Braun J, Schaefer–van Mansfeld H, Van Rijn C, Witteveen E. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 2000;11:559–562.
Ruzicka K, Kapiotis S, Quehenberger P, et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer Coaguchek Plus in various clinical settings. Thromb Res 1997;87:431–440.
Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Ann Intern Med 1995;155:1861–1867.
Chapman DC, Stephens MA, Hamann GL, Bailey LE, Dorko CS. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother 1999;33:775–779.
Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long–term oral anticoagulant therapy. Arch Intern Med 1993;153:1441–1447.
Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long–term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998;92:11–17.
Van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000;84:410–412.
Attermann J, Kynde K, Hasenkam JM. Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer. Thromb Res 1998;92:287–291.
Cachia PG, McGregor E, Adlakha S, Davey P, Goudie BM. Accuracy and precision of the TAS analyser for near–patient INR testing by non–pathology staff in the community. J Clin Pathol 1998;51:68–72.
Kitchen S, Fitzmaurice D, Murray E, et al. Patient self–determined INRs: are they under control? Br J Haematol 2000;108(Suppl 1):49.
Seamark DA, Backhouse S, Barber P, Hichens J, Lee R, Powell R. Validation of current practice and a near patient testing method for oral–anticoagulant control in general practice. J Roy Soc Med 1997;90:657–660.
Kitchen S, Preston FE. Monitoring oral anticoagulant treatment with the TAS near–patient test system: comparison with conventional thromboplastins. J Clin Pathol 1997;50:951–956.
Zweig SE, Meyer BG, Sharma S, Min C, Krakower JM, Shohet SB. Membrane–based, dry–reagent prothrombin time tests. Biomed Instrum Technol 1996; 30:245–256.
Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 1987;88:442–446.
Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991;44:950–953.
Tripodi A, Chantarangkul V, Clerici M, Negri B, Mannucci PM. Determination of the international sensitivity index of a new near–patient testing device to monitor oral anticoagulant therapy. Thromb Haemost 1997;78:855–858.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Besselaar, A.M. Accuracy, Precision, and Quality Control for Point-of-Care Testing of Oral Anticoagulation. J Thromb Thrombolysis 12, 35–40 (2001). https://doi.org/10.1023/A:1012734426811
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1012734426811